HPV-specific innovations and controversies in therapeutic strategies for HPV-associated oropharyngeal carcinoma - Top-Institutions - MDSpire

HPV-specific innovations and controversies in therapeutic strategies for HPV-associated oropharyngeal carcinoma

  • By

  • Yulun He

  • Jiaqi Tang

  • Yun Li

  • Yating Hu

  • Yaodong He

  • Xiaolong Zhang

  • Yanbing Yao

  • Jiale Wang

  • Kunyu Chen

  • Yuqi Wang

  • Huan Li

  • Jianhua Wei

  • June 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The Ohio State University Comprehensive Cancer Center
    The Ohio State University Comprehensive Cancer Center

    Columbus, OH

    Key Differentiators

    • Oncology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Oncology

  • #3

    University of Chicago Medicine
    University of Chicago Medicine

    Chicago, IL

    Key Differentiators

    • Oncology

  • #4

    Cleveland Clinic Cancer Institute
    Cleveland Clinic Cancer Institute

    Cleveland, OH

    Key Differentiators

    • Oncology

  • #5

    Washington University School of Medicine in St. Louis
    Washington University School of Medicine in St. Louis

    St. Louis, MO

    Key Differentiators

    • Oncology

Original Source(s)

HPV-specific innovations and controversies in therapeutic strategies for HPV-associated oropharyngeal carcinoma

  • by Yulun He, Jiaqi Tang, Yun Li, Yating Hu, Yaodong He, Xiaolong Zhang, Yanbing Yao, Jiale Wang, Kunyu Chen, Yuqi Wang, Huan Li, Jianhua Wei

  • June 1, 2026

Related Content

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study

MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen